TD Cowen Maintains Buy on Amgen, Raises Price Target to $381
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Yaron Weber maintains a Buy rating on Amgen (NASDAQ:AMGN) and raises the price target from $360 to $381.
August 07, 2024 | 9:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Yaron Weber maintains a Buy rating on Amgen and raises the price target from $360 to $381.
The raised price target and maintained Buy rating from a reputable analyst can positively influence investor sentiment and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100